arrow
B

Brent A. Hanks

lineberger comprehensive cancer center
H指数:31
被引数:3,888

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase II pilot trial of an indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor (INCB024360) plus a multipeptide melanoma vaccine (MELITAC 12.1) in patients with advanced melanoma, with sequential evaluation of the tumor microenvironment

晚期黑色素瘤患者中吲哚胺2,3-双加氧酶-1(IDO1)抑制剂(INCB024360)联合多肽黑色素瘤疫苗(MELITAC 12.1)的II期初步试验,并序贯评估肿瘤微环境

2026-10-020
OAAI
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy

肿瘤内在NLRP3-HSP70-TLR4轴驱动anti-PD-1免疫治疗期间转移前生态位的发展和过度进展

2022-11-2324
OA
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma

抑制骨髓细胞中的雌激素信号可提高黑色素瘤的肿瘤免疫力

2021-12-0160
OA